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Abstract
Background: PraderWilli syndrome (PWS) is a rare genetic disorder resulting in obesity. The diets for young
children with PWS must balance the importance of preventing development of obesity with the need to
supply sufficient energy and essential nutrients.
Objective: To investigate the nutritional intake for children with PWS 2, 3, and 4 years of age and compare
it with Nordic Nutritional Recommendations (NNR) and intake of healthy controls.
Design: Assessments of food intake for six children 24 years of age were performed twice a year. At the age of
2 and 3 years data was obtained by using food recall interviews and at 4 year of age a pre-coded food-diary
was used.
Results: The energy intake for the 2-year-old children was 3.25 MJ/day (SD 0.85) and for the 3- and 4-year
olds 3.62 MJ/day (SD 0.73) and 4.07 MJ/day (SD 0.39 MJ), respectively. These intakes are 61%, 68%, and
77% of the estimated energy requirements in NNR for healthy 2-, 3- and 4-year-old children, respectively, and
60% and 66% of the energy intakes of 2- and 4-year-old children in reference populations. The children’s
BMI-for-age score and length growth was within the normal range during the study period. The intake of fat
was about 25 E% in all age groups and reduced when compared with reference populations. In 25% of the
assessments the fat intake was 20 E% or below. The intake of iron was below recommendations in all age
groups both with and without supplementation. The mean intake of vitamin D and tocopherol was below
recommendations when intakes were determined excluding dietary supplementations.
Conclusions: More large-scale investigations on nutritional intake are needed to further investigate dietary
challenges for this patient group.
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T
he PraderWilli syndrome (PWS) is a complex,
multisystem disorder of genetic origin due to lack
of paternally active genes in chromosome 15 q11
q13. The birth incidence of the condition is reported to be
1:22,000 to 1:29,000 with no gender or ethnic differences
of distribution (13). The three different genetic mechan-
isms leading to PWS are deletions (70%), maternal
uniparental disomies (UPD) (28%), and imprinting
defects (2%) (4). The major clinical features include
neonatal hypotonia and failure to thrive and childhood
onset of hyperphagia that typically occurs from age
between 2 and 6 years of age, which in turn, will lead
to obesity in the absence of energy restrictions. Other
features include short stature, hypogonadism, learning
disability, developmental delay, and behavioral problems
(46). Hypothalamic dysfunction may be responsible for
many of the clinical features seen in PWS (7).
The management of PWS involves a multidisciplinary
life-long approach to improve quality of life, prevent
complications, and prolong life expectancy. Prevention
and treatment of obesity is essential and depend on a low-
energy and well-balanced diet with rigorous supervision
and restriction of food access, combined with regular
meals and exercise (8).
The nutritional intakes for persons with PWS have
traditionally been described as having two phases. Firstly,
poor feeding and frequent failure to thrive, occurring
from birth to early infancy and secondly, the onset of
hyperphagia leading to obesity. A more complex progres-
sion and development with several nutritional phases
during the first year has also been reported (9).
The energy requirements for children from 8 year of
age and adults with PWS are found to be 2030% reduced
compared with healthy age-matched controls (10, 11).
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explained by reduced metabolic rate and due to altered
body composition with a lower muscle mass (11, 12).
Furthermore, persons with PWS have been reported to
have a more inactive lifestyle (11, 13). There has been less
focus on the energy requirements of young children with
PWS than those of older children and adults. Guidelines
on energy requirements for children with PWS must
therefore be used with caution. Excessive energy intake
may lead to overweight, whereas inadequate energy
intake may have serious consequence for the children’s
growth and development.
Today, many of the children with PWS are diagnosed
during their first month of life due to the presence of
neonatal hypotonia, which leads to genetic testing and
diagnosis. Parents and caregivers will therefore at an early
stage become aware of the high risk for development of
obesity for their children. However, there are no estab-
lished routines in Norway today involving counseling
with a registered dietitian at the time of diagnosis. This
leaves parents and caregivers with the challenges of
preventing development of obesity combined with pre-
senting a diet with sufficient energy and essential
nutrients to ensure optimal growth and development.
To the best of our knowledge there are no systematic
studies published on the actual nutritional intake in
persons with PWS. This is a paradox since specific diet-
regimes are recommended and widely used as part of the
management for this condition (8). The recommended
regime includes reduced access to foods, drinks, and
rigorous supervision. To deprive a person the opportu-
nities to influence his/her own food intake raises im-
portant ethical issues. In PWS restriction of food
availability and strict monitoring is considered to be in
the best interest for the person(s) involved. However, this
also raises the need to make sure the diet is nutritionally
sufficient in all essential nutrients and in accordance with
general recommendations on diets for optimal health and
development. The nutritional intake for young children in
growth and development is especially an important issue.
The aim of this study was to investigate the nutritional
intake for young children with PWS in Norway and to
compare it with Nordic Nutritional Recommendations
(NNR) (14) and with healthy age-matched Norwegian
children as reference population (15, 16). Results pre-
sented suggest that total intake of energy and fat for
young children with PWS is reduced compared with age-
matched reference populations, and that the intake of
micronutrients is low for several nutrients if dietary
supplements are not used.
Subjects
The parents of seven children with PWS born in
Norway from 2000 to 2002 were invited to participate
in this study in 2003. The diagnoses were genetically
verified by florescence in situ hybridization (FISH)
chromosome test and DNA-analysis for the one child
with maternal uniparental disomy (UPD). At the time of
invitation the families were given both written and oral
information about the study. All invited families accepted
the invitation and gave written informed consent to
participate. The study group constituted the total known
population of children alive with PWS in Norway born in
this particular period. All the children in this study were
diagnosed with PWS in their first months of life. One
child died early in the study period and data on six
children are therefore presented here (three male and
three female). The project was approved by Regional
Committee for Medical and Health Research Ethics and
Norwegian Social Science Data Service.
Methods
Four assessments of food intake at the age of 2 and 3
years were performed. The first, third, and fourth
assessments were by food recall interview with parents
and day-care personnel, either at their homes or in the
day-care centers. The second assessment during this
period was completed by only interviewing one of the
parents via telephone. There was approximately a period
of six months between the different assessments. The
interviews were performed by the same person who was a
registered dietitian.
The year the children reached 4 years of age, the
parents recorded the food consumption by using a pre-
coded food-diary in two registration periods separated by
approximately six months, with three or four days of
reporting on each occasion. The pre-coded food-diary
has been developed for and used in national food surveys
in Norway for 4-, 9- and 13-year-old children in the
general population (17).
All the recorded data was encoded and analyzed using
a food database and software systems developed at the
Department of Nutrition, University of Oslo.
Medical background information was collected from
the records of the local hospitals. Data on weight and
height were collected from records of the local maternal
and child health centers. Body mass indexes (BMI) at
different ages are calculated and are presented together
with BMI Z-scores and medical background information
in Table 1.
Data
Descriptive statistics with mean intake and standard
derivations was used to describe the data. The energy
intakes were compared with estimated energy require-
ments in NNR (14) and data from healthy age-matched
Norwegian children in the general population (15, 16).
Similar the intakes of energy-yielding nutrients were
compared with age-matched reference populations (15,
16) and NNR (14). The intake of micronutrients was
Marianne Lindmark et al.
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of these recommendations. For those micronutrients
where the intakes were below recommendations we also
describe the intakes in the reference populations (15, 16).
Intakes of nutrients from dietary supplements are pre-
sented separately together with information on how many
children using supplementations.
Results
The mean total energy intake for the 2-year-old children
with PWS was 3.25 MJ/day, and 3.62 and 4.07 MJ/day
for the 3- and 4-year-old children, respectively. These
energy intakes are 61%, 68%, and 77% of the estimated
energy requirements in NNR for the 2-, 3- and 4-year-old
children, respectively, as can be seen in Table 2. For the
2- and 4-year-old children the corresponding percentages
were 60% and 66%, compared to age-matched children in
the reference populations (15, 16).
The children with PWS had a mean length growth
during the study period of 20.0 cm (SD 4.0). Five of the
six children started growth hormone treatment around
the age of 4 (see Table 1). Mean growth for healthy
children in the same age period is 20.5 cm (18).
The children with PWS have in general a low intake of
fat. The mean energy percent from fat was 24 E% for the
2-year olds, and 25 E% for both 3- and 4-year olds. These
intakes are below the general recommendations for the
population and far below those of the reference popula-
tions. The intakes of both saturated fat and monounsa-
turated fat are reduced when compared with intakes of
the reference populations, as can be seen in Table 3,
and also below recommendations in NNR (14). The
mean intake of polyunsaturated fatty acids (PUFA) was
approximately half of the intake of the reference popula-
tions, when compared as actual intake (g), but only
7% and 12% reduced when the intakes are compared as
Table 1. Medical background information
Genetic
mechanism
Age at start of
GH
a treatment
2 years 3 years 4 years
BMI Z-score (SD) BMI Z-score (SD) BMI Z-score (SD)
Child 1 Deletion 3.8 years 17.5 1.13 17.8 1.40 17.6 1.27
Child 2 Deletion 4.0 years 15.8 0.14 16.9 0.77 14.7 1.0
Child 3 Deletion No treatment
during study period
15.1 0.42 16.5 0.64 16.8 0.86
Child 4 UPD
b 4.0 years 16.2 0.36 15.7 0.07 15.4 0.08
Child 5 Deletion 3.9 years 15.2 0.33 16.5 0.29 15.4 0.16
Child 6 Deletion 4.0 years 16.0 0.04 14.3 1.48 14.5 1.19
aGrowth hormone.
bMaternal uniparental disomy.
Table 2. Daily intake of energy, vitamins, and minerals
c
2 years (n6) 3 years (n6) 4 years (n6)
Mean (SD)
a NNR (%)
b Mean (SD)
a NNR (%)
b Mean (SD)
a NNR (%)
b
Energy (MJ) 3.25 (0.85) 61 3.62 (0.73) 68 4.07 (0.39) 77
Retinol (mg) 2,019 (1,292) 576 1,384 (953) 395 1,025 (565) 292
Vitamin D (mg) 15.6 (14.5) 208 15.1 (6.2) 201 7.2 (4.5) 96
Tocopherol (mg) 13.2 (11.6) 264 15.1 (5.4) 302 9.8 (3.9) 195
Thiamin (mg) 1.2 (0.5) 200 1.1 (0.6) 183 1.2 (0.4) 200
Riboflavin (mg) 1.54 (0.75) 220 1.48 (0.83) 211 1.58 (0.52) 166
Ascorbic acid (mg) 80 (32) 266 52 (24) 173 63 (21) 210
Calcium (mg) 596 (332) 99 602 (111) 100 710 (117) 118
Iron (mg) 6.9 (3.2) 86 6.7 (3.7) 84 7.7 (3.5) 96
Magnesium (mg) 144 (57) 120 157 (35) 131 180 (36) 150
aStandard deviation.
bPercent of Nordic Nutrition Recommendations 2004.
cDietary supplements included.
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PUFA was within recommendations in NNR (14).
In 25% of the assessments the intake of fat was 20 E%
or less of the total energy intake. In most of these
assessments the intakes of PUFA were below recommen-
dations (14).
The intake of protein was higher when expressed as
percent of total energy intake in the PWS population
compared with the reference populations for both the 2-
and 4-year olds. However, when expressed as gram
protein per kg the intake was 3.0 g/kg for the 2-year-
old children with PWS and 3.7 g/kg in the reference
population (15). For the 3-year olds the intakes in the
PWS group was 3.1 g/kg, and for the 4-year-old children
3.2 g/kg in the PWS group and 2.9 g/kg in the reference
population (16). The intake of protein in the PWS groups
was within the recommended level of intake in NNR on
all assessments (14).
The intake of carbohydrates expressed as percent of
total energy intake was similar both in children with PWS
at different age and the reference populations, as can be
seen in Table 3. The intakes of carbohydrates for the
children with PWS were within the NNR recommenda-
tions (14). However, the mean intakes of sugar for the
children with PWS were considerably lower than intakes
in the reference populations (15, 16), and within the
recommendations (14).
In general, the diets contained enough water-soluble
vitamins even without supplementations. However, the
mean intake of vitamin D was only 26%, 38%, and 32%
of NNR for the 2-, 3-, and 4-year olds, respectively, when
excluding the dietary supplements. Similarly the intake of
tocopherol was 47%, 45%, and 57% of NNR for the 2-, 3-,
and 4-year olds, respectively. However, it is worth noting
that the intake of vitamin D in the reference population
was only 35% of NNR in both the 2- and 4-year-old
children when calculated without supplementations,
whereas the intake of tocopherol was 84% and 90% of
NNR for the 2- and 4-year-old children in the reference
population (15, 16).
The mean intake of iron in the PWS group was found
to be somewhat below NNR in all age groups (8496%),
as can be seen in Table 2. Similar levels of intakes have
also been reported in the reference population with an
intake at 89% and 83% of NNR in the 2- and 4-year-old
children (15, 16).
The mean intake of calcium reached the recommended
level in the PWS children, but the intakes differed to a
large extent within the 2- and 3-year-old groups. Three of
six children at 2 years of age and two of those 3 years of
age did not reach the recommended level of intake. The
children with low intake of calcium drank milk only
occasionally and mainly used dairy products as part of
food preparations. The mean intake of calcium in the
reference population was 129% and 113% of NNR for the
2- and 4-year-old children, respectively (15, 16).
The use of dietary supplementation and how this
affects the mean intake of energy, vitamins, and minerals
in the different age-groups are presented in Table 4.
The children with PWS used supplementation with either
cod liver oil, multivitamins, multivitamin-minerals, or a
combination of these. Most children used one dietary
supplement but some used a combination of two. At the
age of 2 years, one child used a combination of cod liver
oil and multivitamin-mineral. At the age of 3 years, none
combined several supplements. Finally, at 4 years of age
one child used a combination of cod liver oil and
multivitamin-minerals, whereas one child used cod liver
oil and multivitamins. Cod liver oil increases the intake of
the fat-soluble vitamins as well as PUFA.
Discussion
This study on the nutritional intake for children with
PWS involves a small number of participants. Seven
children were recruited for the study. Based on data on
birth rate in Norway for 20002002 (19) divided with the
Table 3. Daily intake of energy-yielding nutrients
2 years (n6) 3 years (n6) 4 years (n6)
Mean (SD)
a RP (SD)
a,b Mean (SD)
a Mean (SD)
a RP (SD)
a,c
Fat E% 23.8 (7.3) 33.3 (5.1) 24.8 (5.1) 24.5 (4.3) 32.5 (4.8)
Saturated fat E% 7.6 (2.8) 14.2 (2.7) 8.3 (2.5) 9.3 (2.3) 14.2 (2.5)
Monounsaturated fat E% 7.9 (3.3) 10.4 (1.8) 8.1 (1.8) 8.0 (1.8) 9.9 (1.7)
Polyunsaturated fat E% 5.6 (2.4) 5.7 (1.9) 5.4 (1.9) 5.0 (1.4) 6.0 (1.7)
Protein E% 16.6 (3.7) 13.4 (1.8) 18.1 (2.9) 20.3 (2.1) 14.1 (2.5)
Carbohydrate E% 57.3 (7.1) 53.3 (5.6) 56.8 (6.6) 55.2 (5.8) 53.5 (5.5)
Sugar E% 4.3 (5.6) 11.7 (5.8) 2.6 (2.0) 5.0 (4.9) 15.2 (5.5)
aStandard deviation.
bMean intake in Reference population (15).
cMean intake in Reference population (16).
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an incidence of 1:24,447. Given the reported incidence for
PWS we conclude that our study most likely include
all children alive with PWS born in Norway from
2000 to 2002.
Self-reported methods as those used in this study may
be subject to bias and underestimations of energy intake
have been reported (17, 20). We collected data twice a
year to limit the difference in dietary intake due to
seasonal differences. The pre-coded food-diary used for
the 4-year-old children has been validated and shown to
give a lower intake of energy, fat, and sugar compared to
24-h recall (21). Furthermore, compared to energy
expenditure data the underreporting with this method
was 18% (22).
In this study we show that the children with PWS have
approximately 2040% reduced energy intake compared
to NNR and surveys among other Norwegian children
their age (14). Children with PWS are expected to have a
reduced requirement for energy, even though this has not
been a subject of proper investigations and the literature
mostly refers to clinical experiences (9). The literature
suggested that the energy intakes are restricted to prevent
obesity, but there is some disagreement at what age the
reduced energy requirements starts and the extent of
energy restrictions required (9). Uncertainties on energy
requirements for small children with PWS and the
widespread use of growth hormone treatment seen today,
emphasize the need for more investigations on energy
requirements.
We found no support for reduced growth due to
reduced energy intake among the children in our study.
We also found normal BMI-for-age throughout the study
period. These findings support the notion that energy
intake was appropriate for the children studied. In
another study a fat-reduced and carbohydrate modified
diet providing 10 kcal/cm (42 kJ/cm) of height starting at
the second year of life, resulted in shorter stature when
compared with a control group of persons with PWS
diagnosed at a later stage in life (23).
Our data suggest that some parents and caregivers of
children with PWS restrict the intake of fat too much.
Very low intakes of fat (e.g. below 20 E% of total energy
intake) increase the risk for inadequate intake of PUFA.
This may have negative consequences for brain and
nervous system development (24). This finding indicates
that parents of children with PWS may need professional
assistance on food selection. The guidance should include
information on foods with appropriate fat content and
how much fat the children need.
High intakes of sugar are one of the nutritional
challenges for children in Norway (25). More than 50%
of the children 2 years of age (15), and 80% of children 4
years of age (16) in the general population consume more
sugar than recommended. The intake of sugar in the
PWS population was considerably below the intakes of
the reference populations. The difference in intake of
sugars is mainly explained by the difference in consump-
tion of soft drinks.
The data presented also show that children with PWS
have low intake of several essential nutrients. This is
mainly due to the reduced intake of energy. Our findings
suggest that children with PWS may need dietary
supplementation of vitamin D and tocopherol, and the
minerals iron and calcium. Calcium could also be
increased by increasing the diet contents of low-fat dairy
products. Due to the increased reported risk for osteo-
porosis supplementation of vitamin D and calcium are
recommended for individuals with PWS (26). Many of
the children in our study used dietary supplementation,
but none used calcium supplementation even though this
is a clear recommendation for the patient group.
Parents and caregivers of young children with PWS
should be offered evaluations of the dietary intake by a
registered dietitian to ensure optimal growth and devel-
opment. Attention should be given to the intake of
energy, fat, vitamin D, tocopherol, iron, and calcium.
More large-scale investigations on the dietary intake of
people with PWS should be performed.
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Table 4. Daily intake of energy, vitamins, and minerals from dietary
supplements
a
2 years 3 years 4 years
Mean N
b Mean N
b Mean N
b
Energy (MJ) 0.02 2 0.14 3 0.08 2
Retinol (mg) 1,571 5 980 5 359 5
Vitamin D (mg) 13.6 5 12.2 5 4.8 4
Tocopherol (mg) 10.8 5 12.8 5 6.9 4
Thiamin (mg) 0.55 3 0.37 2 0.32 3
Riboflavin (mg) 0.63 3 0.44 2 0.3 3
Ascorbic acid (mg) 22 3 16 2 12 3
Calcium (mg) 0 0 0 0 0 0
Iron (mg) 0 0 0.6 1 1.7 1
Magnesium (mg) 13 1 13 1 0 0
aType of dietary supplements used: Cod liver oil, multivitamin, and
multivitamin minerals.
bNumber of children using dietary supplement of the nutrient.
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